JNJ trade ideas
JNJ: Bearish Breakdown Analysis 4H (Apr. 26)X FORCE GLOBAL ANALYSIS:
Johnson & Johnson has shown great momentum in its small rally over the past few weeks. However, technicals demonstrate signs of prices having temporarily topped out.
Technical Analysis
- The first thing we spot is a textbook bearish divergence.
- Prices form higher highs, while the Relative Strength Index (RSI) forms lower highs
- The Moving Average Convergence Divergence (MACD) has formed a death cross, with increasing bearish histograms
- We have broken down from the ascending parallel channel, and the support has now become resisance
- Prices have been testing the upper resistance of the Bollinger bands, and a test of the lower support is highly likely
- We have two price gaps on the 4H chart, waiting to get potentially filled
- The volume is decreasing as bearish tensions increase
What We Believe
Although JNJ is a fundamentally sound stock, and still great for the long run, short term technicals demonstrate a potential downside.
Trade Safe.
4.24.2020 JNJ Bearish Weekly Divergence + under resistanceUnder resistance trend
Good play to short with a stop above high.
-NFA
JNJ : Day TradingThis share closes today at its top price $155.51, for the first time of history.
I think we have a good support at $154.
If the share moves up above $154, then BUY. It would have a potential to hit $160.
Like and Follow to see more.
Johnson & Johnson is an American pharmaceutical company founded in 1886.
It produces pharmaceutical and medical devices, hygiene products, cosmetics and also provides related services to consumers and healthcare professionals.
JNJ long position on 240 chart. Anyone with me?There is a potential for some 5% profit, will go long NYSE:JNJ today.
JNJ resistance areaJNJ could go touch a new all time high, but for the moment we are in a long term daily resistance area, I'm not short but at short term if you have JNJ shares I recommend to sell them. Next JNJ signal will be published on this account
JNJ short term predictionThe current level of $136.18 is a safe entry/hold. If price is not dropping below $130 range until early June/July, there is a higher probability for uptrend targeting $150-160 range.
JNJ cup & handle BO on volume (Covid 19 play)Johnson & Johnson $JNJ BO a Cup & Handle with some nice volume.
NYSE:JNJ
JOHNSON & JOHNSON (JNJ) Monthly, Weekly & DailyTrades made when the monthly, weekly and daily arrows are pointing in the same direction
are the most profitable.
For best results trade in the direction of the trend.
The Linear Regression channel is used to determine trend direction. The Linear Regression is set at 2 -2 30.
When a green Henikin Ashi candle intersects with the linear regression upper deviation line (green line) and both indicators intersect with a Djinn prediction date a sell is triggered.
When a red Henikin Ashi candle intersects with the linear regression lower deviation line (red line) and both indicators intersect with a Djinn prediction date a buy is triggered.
This trading strategy works on daily, weekly and Monthly Djinn Predictive charts.
This is not trading advice. Trade at your own risk.
Head and Shoulders on J&JPrice consolidates below the resistance level 134.25-136.55 and the trend reversal model was formed. If bulls manage to break through this level, I expect price growth.
Stocks to Watch - JNJJohnsons and Johnsons is a stock worth buying at the moment and holding for the next year or so. They are pioneering a vaccine for the coronavirus and is due to be administered late 2020 early 2021.
$JNJ Breaks Out as Company Moves into Coronavirus LottoJNJ just entered the fray as the newest bona fide COVID-19 "play" given its claim to have a serious vaccine candidate.
The stock broke above range and MA resistance to kick off the week, and still has a bullish trend on a long time frame according to the Ichimoku Cloud indicator.
JOHNSON & JOHNSON (JNJ) TOP-DOWN ANALYSIS & TRADING PLAN!
hey guys,
JNJ is retesting the major recently broken trendline.
Chances are high that the market may drop from that and here is how we can catch this wave!
pay attention to a horizontal decision range on 1H.
bearish breakout of it will be a perfect trigger to short!
initial target - 111.0
then apply trailing stop to catch occasional panic selloff.
if the market goes above the falling trendline on 4H, our setups will be invalid and our bias shifts to bullish!
good luck!
J&J MOVING TOWARDS $118, $114 SL $127.4SHORT J&J : Small Trade Good Trading Gain %
IT MAY GO DOWN TOWARDS $118, $114 SL $127.4
Johnson § Johnson $JNJJohnson § Johnson is one of the companies working on coronavirus treatments§vaccines. They need to develop one otherwise as technically monthly looks very ugly
JNJ OpportunityHarmonic line down there waiting for it, if it can hit the green line, could be a great spot to get into JNJ
Johnson and Johnson D1Johnson & Johnson is a large company in the production of hygiene products and body care products. The company's products are sold worldwide, which gives it a very good profit. Its products are of rather high quality because in the USA there are very strict requirements for product quality, which is what impresses the buyer. At a time when outbreaks of the Corono virus are observed all over the planet and panic reigns, the need for the company's products is increased. The media daily speaks of enhanced hygiene measures to prevent illness. Many inhabitants of the planet have a fear of the disease, which leads to increased expenses on hygiene products. In most countries of the world quarantine has been introduced, which will last at least another month. This situation will enable the company to make good profits. A Gann box is installed on the chart, which can approximately show the maximum price marks for the near future, which coincide with the end of the quarantine period if it is not extended.
Johnson & Johnson Bullish On COVID-19 vaccine $jnjJ&J has tasked dozens of scientists to work on a vaccine for the disease, Paul Stoffels, a physician who is the New Brunswick, N.J., company's chief scientific officer, told CNBC.
"We are pretty confident we can get something made that will work and will stay active for the longer term," Stoffels told the business-news network.
Source Thestreet
